What's likely to happen on drug prices, and what you can ignore
President Trump may have gone from accusing pharmaceutical companies of "getting away with murder" to meeting with the CEOs of those companies but the fight over drug prices is far from over.
What the president has called for in the past — drug price negotiations, presumably in Medicare — is far from the top of the list of what's likely to pass through a Republican-controlled Congress, and he's talking about that less now anyway. Instead, he's aligning more with congressional Republicans in calling for market reforms to create more competition faster.
And while Trump and his Twitter account make predicting what will happen an imprecise science, we've created a list of what's likely to happen on the drug price front, what may happen and what's probably not going to go anywhere.